Oscient Pharmaceuticals Corporation
Records under this name other than patents Oscient Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Oscient Pharmaceuticals Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,026,281 | Treating metabolic syndrome with fenofibrate Formerly held Term ended Term ended Apr 22, 2025 · USPTO record | Term ended | Term ended Apr 22, 2025 | USPTO record |
| US 7,317,001 | Use of Ramoplanin to Treat Diseases Associated with the Use of Antibiotics Formerly held Term ended Term ended Dec 21, 2024 · High confidence | Term ended | Term ended Dec 21, 2024 | High confidence |
| US 6,720,305 | Injectable Formulations Containing Ramoplanin Formerly held Term ended Term ended Jul 19, 2019 · High confidence | Term ended | Term ended Jul 19, 2019 | High confidence |
| US 8,907,067 | Nucleotide and Amino Acid Sequences Relating to Respiratory Diseases and Obesity No holder on record Lapsed on the fee record Ended Dec 9, 2018 · Medium confidence | Lapsed on the fee record | Ended Dec 9, 2018 | Medium confidence |
| US 7,501,118 | Novel Human Gene Relating to Respiratory Diseases and Obesity No holder on record Lapsed on the fee record Ended Mar 10, 2017 · Medium confidence | Lapsed on the fee record | Ended Mar 10, 2017 | Medium confidence |
| US 7,407,804 | Novel Human Genes Relating to Respiratory Diseases and Obesity Lapsed on the fee record Ended Aug 5, 2016 · Low confidence | Lapsed on the fee record | Ended Aug 5, 2016 | Low confidence |
| US 6,737,519 | Human genes relating to respiratory diseases and obesity Lapsed on the fee record Ended May 18, 2016 · USPTO record | Lapsed on the fee record | Ended May 18, 2016 | USPTO record |
| US 8,124,734 | Novel Human Genes Relating to Respiratory Diseases and Obesity No holder on record Lapsed on the fee record Ended Feb 28, 2016 · Medium confidence | Lapsed on the fee record | Ended Feb 28, 2016 | Medium confidence |
| US 8,105,826 | Nucleotide and Amino Acid Sequences Relating to Respiratory Diseases and Obesity No holder on record Lapsed on the fee record Ended Jan 31, 2016 · Medium confidence | Lapsed on the fee record | Ended Jan 31, 2016 | Medium confidence |
| US 7,928,200 | Novel Human Genes Relating to Respiratory Diseases and Obesity No holder on record Lapsed on the fee record Ended Apr 19, 2015 · Medium confidence | Lapsed on the fee record | Ended Apr 19, 2015 | Medium confidence |